This paper is only available as a PDF. To read, Please Download here.
Abstract
Concern about the use of silicone gel as a filler for breast prostheses has stimulated interest in other materials. We have evaluated the Misti Gold prosthesis which contains a “bio-oncotic” gel of low molecular weight Polyvinylpyrrolidone (PLASDONE 24AUK). Our experience of its use in breast augmentation is that the aesthetic results obtained with retromammary placement are inferior to those obtained from a silicone gel filled prosthesis. Nonetheless there are theoretical advantages for its use which will need to be considered in the light of recent regulatory decisions.
References
- The effectiveness of alpha-tocopherol (Vitamin E) in reducing the incidence of spherical contracture around breast implants.Plastic and Reconstructive Surgery. 1981; 68: 696
- Radiolucent prosthetic gel.Plastic and Reconstructive Surgery. 1991; 87: 885
- Silicone gel breast implants.Department of Health circular. 1992; 1 (PL/CMO (92)): 1
- Breast implants: Boom market threatened with bust.Trends in Health Business. 1989; 1 (December): 1
- Textured or smooth implants for breast augmentation? A prospective controlled trial.British Journal of Plastic Surgery. 1991; 44: 444
Cranstone P. (1992). Bioplasty Limited, Reading UK.Personal Communication.
- Rate and incidence of capsular contracture: a comparison of smooth and textured silicone double-lumen breast prostheses.Plastic and Reconstructive Surgery. 1991; 87: 879
- PVP: A critical review of the kinetics and toxicology of polyvinylpyrrolidone (Povidone).Lewis publishers Inc, Chelsea, Mi1990
Article info
Publication history
Accepted:
September 16,
1992
Received:
April 28,
1992
Identification
Copyright
© 1993 The British Association of Plastic Surgeons. Published by Elsevier Inc.
